Skip to content
MarketNewsAPI
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]

MORN · NASDAQ

Morningstar, Inc.

$224.00 +1.65 (+0.74%)

Company overview

Morningstar, Inc. provides independent investment research services in North America, Europe, Australia, and Asia. The company offers web-based tools, investment data, fundamental equity and manager research, private capital markets research, credit and fund ratings, index services, and environmental, social, and governance (ESG) ratings. Its investment offerings include managed investment products, publicly listed and private companies, fixed income securities, and real-time global market data for financial advisors, asset managers, retirement plan providers and sponsors, and individual and institutional investors.

Sector
Financial Services
Industry
Financial - Data & Stock Exchanges
Exchange
NASDAQ
Market cap
$8.4B
Employees
11,115
Headquarters
Chicago, IL
Website
morningstar.com
CEO
Kunal Kapoor
Listed
May 3, 2005
P/E
22.70
Dividend yield
1.09%

Company financials

Revenue
$2.5B
Gross profit
$1.5B
Operating income
$568M
EBITDA
$773M
Net income
$403M
EPS
$9.87
Total assets
$4B
Total debt
$1.9B
Gross margin
61.71%
Net margin
16.06%
Earnings yield
4.41%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

138.11160.94183.78206.62229.45
MORN 1D NASDAQ O221.80H225.21L221.00C224.98+1.65 (+0.74%)Vol69.23K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
MORN Stock news Vanguard Morningstar Growth ETF vs. Vanguard Information Technology ETF: Here's Which One I Believe Is the Clear Long-Term Winner. The Motley Fool
MORN Stock news Robinhood Markets Reports Earnings on Oct. 27. Is It a Better Buy Than Morningstar? The Motley Fool
MORN Stock news CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026? The Motley Fool
MORN Stock news Financial Comparison: Morningstar (NASDAQ:MORN) vs. Bain Capital Specialty Finance (NYSE:BCSF) Defense World
MORN Stock news $10,000 a Month at 67 for a Single Retiree Who Still Rents: What Will It Really Look Like? 247 Wallst
MORN Press release Retail Trading Platforms Post Record Quarters as Investor Apps Multiply Wall Street Investor News Commentary - Four publicly listed retail investing platforms now report more than 41 million funded accounts between them,... PR Newswire
MORN Stock news Contrasting Robinhood Markets (NASDAQ:HOOD) and Morningstar (NASDAQ:MORN) Defense World
MORN Press release CLIK Notes Morningstar Quantitative Fair Value of $2.02 vs Last Close of $1.09; 46% Discount; Book Value Yield in Global Top 1% GlobeNewsWire
MORN Stock news Active ETF Inflows Hit Record $576 Billion Through September ETF Trends
MORN Stock news Morningstar Inc (MORN) Stock Up 3.5% and Still Undervalued -- GF Score: 91/100 GuruFocus
MORN Stock news Advisors Adopt AI Fast, but Still Aren't Getting Their Time Back, Says 2026 Morningstar Investor Perspectives Advisor Study Business Wire
MORN Stock news Micron's Highest Price Target on Wall Street Is Now $2,100 24/7 Wall Street
MORN Stock news Micron Stock Slips Despite Record Q4, Analyst Price Hikes. Here's Why MU Stock Is Still a Buy 24/7 Wall Street
MORN Press release Morningstar Announces New Global Headquarters at Chicago's Thompson Center and $5 Million Community Investment Donation Business Wire
MORN Stock news Morningstar, Inc. to Announce Third-Quarter 2026 Financial Results on Oct. 28 Business Wire
MORN Stock news 8,334 Morningstar, Inc. $MORN Shares Sold by Corient Private Wealth LP Defense World
MORN Press release Morningstar Completes Quarterly Reconstitution for Morningstar Market Indexes Business Wire
MORN Press release Morningstar Publishes 2026 Health Savings Account Landscape With Updated Provider Assessments and Industry Trends Business Wire
MORN Stock news Morningstar, Inc. Declares Quarterly Dividend of 50 Cents Per Share Business Wire
MORN Press release Morningstar Survey: Asset Owners Increase U.S. and Private Market Exposure as AI Risks Rise Business Wire
See more
FAQ

Questions about Morningstar, Inc.

What does Morningstar, Inc. do?
Morningstar, Inc. provides independent investment research services in North America, Europe, Australia, and Asia. The company offers web-based tools, investment data, fundamental equity and manager research, private capital markets research, credit and fund ratings, index services, and environmental, social, and governance (ESG) ratings. Its investment offerings include managed investment products, publicly listed and private companies, fixed income securities, and real-time global market data for financial advisors, asset managers, retirement plan providers and sponsors, and individual and institutional investors.
What is MORN's market cap?
Morningstar, Inc. (MORN) is a listed stock with a live quote. The latest market cap on this page is $8.4B.
Where is Morningstar, Inc. headquartered?
Morningstar, Inc. is headquartered in Chicago, IL.
How do I get MORN news from the API?
Call GET /v1/news?tickers=MORN. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does MORN news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for MORN, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the MORN price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs